NOVARTIS AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 94.21 CHF | -0.78% |
|
+1.62% | +11.03% |
| Jun. 07 | Abu Dhabi, Novartis to Collaborate on Genomics Research for Cancer Therapy | MT |
| Jun. 07 | Novartis, Roche's Genentech Among Companies Facing Italian Competition Watchdog Inquiry Over Eye Drug | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 216B | ||||||
| 765B | ||||||
| 354B | - | - | - | - | ||
| 331B | ||||||
| 299B | ||||||
| 248B |
- Stock Market
- Equities
- NOVN Stock
- Charts Novartis AG
- Sector Chart
